Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001209191-21-070631 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-12-20	2021-12-16	RXRX	Larson Tina Marriott	Pres, COO	S - Sale	$18.74	-2,500	48.8K	-5%	-$46.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-12-16	S	D	1,040	$19.17	47,800	D	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $18.69 to $19.55 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2021-12-16	S	D	300	$19.78	47,500	D	—	—	(F4) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $19.69 to $19.93 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
3	Common	Class A Common Stock	2021-12-16	S	D	1,160	$18.09	48,840	D	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $17.63 to $18.53 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.